Craig Wilson

4.4k total citations · 2 hit papers
28 papers, 3.3k citations indexed

About

Craig Wilson is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Craig Wilson has authored 28 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Molecular Biology and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Craig Wilson's work include Diabetes Treatment and Management (17 papers), Diabetes Management and Research (5 papers) and Peptidase Inhibition and Analysis (4 papers). Craig Wilson is often cited by papers focused on Diabetes Treatment and Management (17 papers), Diabetes Management and Research (5 papers) and Peptidase Inhibition and Analysis (4 papers). Craig Wilson collaborates with scholars based in United States, France and United Kingdom. Craig Wilson's co-authors include P. Fleck, Christopher P. Cannon, George L. Bakris, William B. White, Faı̈ez Zannad, William C. Cushman, Cyrus R. Mehta, Stuart Kupfer, Alfonso T. Perez and Richard M. Bergenstal and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of the American Chemical Society.

In The Last Decade

Craig Wilson

26 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes

2013 1.9k citations William B. White, Christopher P. Cannon et al. New England Journal of Medicine profile →
Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial

2015 551 citations Faı̈ez Zannad, Christopher P. Cannon et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Craig Wilson United States	15	3.0k	1.1k	958	673	630	28	3.3k
Alfonso T. Perez United States	7	2.8k 0.9×	1.3k 1.2×	882 0.9×	676 1.0×	464 0.7×	8	3.2k
P. Fleck United States	27	4.3k 1.5×	1.6k 1.5×	1.5k 1.5×	699 1.0×	1.0k 1.7×	38	4.7k
Peter P. Stein United States	22	4.3k 1.5×	1.8k 1.6×	1.7k 1.7×	567 0.8×	833 1.3×	27	4.9k
Frans Van de Werf Belgium	8	1.9k 0.7×	733 0.6×	666 0.7×	611 0.9×	313 0.5×	16	2.3k
Thomas Meinicke Germany	22	2.5k 0.9×	1.0k 0.9×	971 1.0×	405 0.6×	317 0.5×	35	2.8k
Monica Ligueros‐Saylan United States	25	2.0k 0.7×	760 0.7×	1.1k 1.2×	454 0.7×	588 0.9×	51	3.1k
Hans‐Juergen Woerle Germany	32	4.1k 1.4×	1.6k 1.4×	1.9k 2.0×	388 0.6×	652 1.0×	61	4.4k
Peter Öhman United States	19	5.1k 1.7×	2.0k 1.7×	1.6k 1.7×	1.1k 1.6×	533 0.8×	32	5.6k
Samuel S. Engel United States	5	1.7k 0.6×	654 0.6×	549 0.6×	430 0.6×	276 0.4×	6	1.9k
Sanjay Patel United Kingdom	21	1.9k 0.6×	788 0.7×	829 0.9×	178 0.3×	514 0.8×	67	2.3k

Countries citing papers authored by Craig Wilson

Since Specialization

Citations

This map shows the geographic impact of Craig Wilson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig Wilson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig Wilson more than expected).

Fields of papers citing papers by Craig Wilson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig Wilson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig Wilson. The network helps show where Craig Wilson may publish in the future.

Co-authorship network of co-authors of Craig Wilson

This figure shows the co-authorship network connecting the top 25 collaborators of Craig Wilson. A scholar is included among the top collaborators of Craig Wilson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig Wilson. Craig Wilson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Estrada, Chelsea C., Craig Wilson, Robert Bronstein, et al.. (2024). Induction of plasmalemmal vesicle-associated protein exacerbates glomerular endothelial injury in thrombotic microangiopathy. American Journal of Physiology-Renal Physiology. 328(2). F190–F203. 1 indexed citations

Grinham, Alistair, Carissa J. Klein, Catherine E. Lovelock, et al.. (2024). Nitrogen loading resulting from major floods and sediment resuspension to a large coastal embayment. The Science of The Total Environment. 918. 170646–170646. 9 indexed citations

Grinham, Alistair, et al.. (2021). Event loading drives distribution of the organochlorine pesticide metabolite DDE in a sub-tropical river system, Brisbane River, Australia. Marine Pollution Bulletin. 170. 112671–112671. 6 indexed citations

Garlo, Katherine, William B. White, George L. Bakris, et al.. (2018). Kidney Biomarkers and Decline in eGFR in Patients with Type 2 Diabetes. Clinical Journal of the American Society of Nephrology. 13(3). 398–405. 26 indexed citations

Heller, Simon, Richard M. Bergenstal, William B. White, et al.. (2017). Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: T he EXAMINE trial. Diabetes Obesity and Metabolism. 19(5). 664–671. 41 indexed citations

Shimada, Yuichi J., Christopher P. Cannon, Yuyin Liu, et al.. (2016). Ischemic cardiac outcomes and hospitalizations according to prior macrovascular disease status in patients with type 2 diabetes and recent acute coronary syndrome from the Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care trial. American Heart Journal. 175. 18–27. 5 indexed citations

White, William B., Stuart Kupfer, Faı̈ez Zannad, et al.. (2016). Cardiovascular Mortality in Patients With Type 2 Diabetes and Recent Acute Coronary Syndromes From the EXAMINE Trial. Diabetes Care. 39(7). 1267–1273. 48 indexed citations

Zannad, Faı̈ez, Christopher P. Cannon, William C. Cushman, et al.. (2015). Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial. The Lancet. 385(9982). 2067–2076. 551 indexed citations breakdown →

White, William B., Craig Wilson, Richard M. Bergenstal, et al.. (2015). ACE INHIBITOR USE AND MAJOR CARDIOVASCULAR OUTCOMES IN TYPE 2 DIABETES TREATED WITH THE DPP-4 INHIBITOR ALOGLIPTIN. Journal of the American College of Cardiology. 65(10). A1411–A1411. 1 indexed citations

10.

White, William B., Stuart Kupfer, Steven Nissen, et al.. (2014). CARDIOVASCULAR MORTALITY IN PATIENTS WITH TYPE 2 DIABETES AND RECENT ACUTE CORONARY SYNDROMES FROM THE EXAMINE TRIAL. Journal of the American College of Cardiology. 63(12). A116–A116. 6 indexed citations

11.

Bron, Morgan, Craig Wilson, & P. Fleck. (2014). A Post Hoc Analysis of HbA1c, Hypoglycemia, and Weight Change Outcomes with Alogliptin vs Glipizide in Older Patients with Type 2 Diabetes. Diabetes Therapy. 5(2). 521–534. 7 indexed citations

12.

Raalte, Daniël H. van, Renate E. van Genugten, Björn Eliasson, et al.. (2014). The effect of alogliptin and pioglitazone combination therapy on various aspects of β-cell function in patients with recent-onset type 2 diabetes. European Journal of Endocrinology. 170(4). 565–574. 38 indexed citations

13.

Zannad, Faı̈ez, Christopher P. Cannon, William C. Cushman, et al.. (2014). ALOGLIPTIN IN PATIENTS WITH TYPE 2 DIABETES AFTER ACUTE CORONARY SYNDROMES: HEART FAILURE OUTCOMES AND CARDIOVASCULAR SAFETY IN HEART FAILURE PATIENTS. Journal of the American College of Cardiology. 63(12). A117–A117. 12 indexed citations

14.

White, William B., Christopher P. Cannon, Simon Heller, et al.. (2013). Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes. New England Journal of Medicine. 369(14). 1327–1335. 1857 indexed citations breakdown →

15.

White, William B., George L. Bakris, Richard M. Bergenstal, et al.. (2011). EXamination of CArdiovascular OutcoMes with AlogliptIN versus Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome (EXAMINE). American Heart Journal. 162(4). 620–626.e1. 128 indexed citations

16.

Rosenstock, Julio, Silvio E. Inzucchi, Jochen Seufert, et al.. (2010). Initial Combination Therapy With Alogliptin and Pioglitazone in Drug-Naïve Patients With Type 2 Diabetes. Diabetes Care. 33(11). 2406–2408. 102 indexed citations

17.

Pratley, Richard E., Thérèse McCall, P. Fleck, Craig Wilson, & Qais Mekki. (2009). Alogliptin Use in Elderly People: A Pooled Analysis from Phase 2 and 3 Studies. Journal of the American Geriatrics Society. 57(11). 2011–2019. 64 indexed citations

18.

Pratley, Richard E., et al.. (2009). Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin added to pioglitazone in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study. Current Medical Research and Opinion. 25(10). 2361–2371. 117 indexed citations

19.

Wilson, Craig. (1980). Rehearsal for a United Nations: The Hot Springs Conference. Diplomatic History. 4(3). 263–282. 5 indexed citations

20.

Wilson, Craig & John Carter. (1974). State of the art—gas turbine noise control. The Journal of the Acoustical Society of America. 55(S1). S35–S36. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact